Stephen Saad - Aspen Pharmacare Group Director
| APN Stock | 17,378 831.00 5.02% |
Director
Stephen Saad is Group Director of Aspen Pharmacare Holdings
| Age | 59 |
| Phone | 27 31 580 8600 |
| Web | https://www.aspenpharma.com |
Aspen Pharmacare Management Efficiency
The company has return on total asset (ROA) of 0.0499 % which means that it generated a profit of $0.0499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.095 %, meaning that it generated $0.095 on every $100 dollars invested by stockholders. Aspen Pharmacare's management efficiency ratios could be used to measure how well Aspen Pharmacare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | DIRECTOR Age | ||
| Vikas Mehta | CA Sales Holdings | N/A | |
| Mark CA | Frontier Transport Holdings | 69 | |
| CA CA | AfroCentric Investment Corp | 50 | |
| Nicholas Bofilatos | Allied Electronics | 41 | |
| Avsharn Bachoo | AfroCentric Investment Corp | N/A | |
Management Performance
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 |
Aspen Pharmacare Holdings Leadership Team
Elected by the shareholders, the Aspen Pharmacare's board of directors comprises two types of representatives: Aspen Pharmacare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspen. The board's role is to monitor Aspen Pharmacare's management team and ensure that shareholders' interests are well served. Aspen Pharmacare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspen Pharmacare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Capazorio, Group Director | ||
| Lorraine Hill, Group Pharmacist | ||
| Zizipho Mmango, Group Officer | ||
| Carnie Linde, Group Head | ||
| BCom BCom, Group Advisor | ||
| Dip MBA, Group Officer | ||
| ACIS BProc, Group Sec | ||
| Stavros Nicolaou, Group Trade | ||
| Trevor Ziman, Regional Pacific | ||
| Stephen Saad, Group Director |
Aspen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aspen Pharmacare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 78.78 B | |||
| Shares Outstanding | 444.95 M | |||
| Shares Owned By Insiders | 19.32 % | |||
| Shares Owned By Institutions | 60.77 % | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 1.60 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aspen Stock
Aspen Pharmacare financial ratios help investors to determine whether Aspen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspen with respect to the benefits of owning Aspen Pharmacare security.